Dr. Lal Path Labs Ltd. Share Price Today
Techno Funda Ratings
Key Metrics
Current Price
₹1732.7Market Cap
₹ 28,287 Cr.Stock P/E
54.2ROE
22.3 %RSI
57.44Trend
BullishShare Price Chart
Technical Commentary
Buy or Sell Analysis
Company Overview
Dr. Lal PathLabs Limited is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where patients and healthcare providers are offered a broad range of diagnostic and related healthcare tests and services for use in: core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. The services of DLPL are aimed at individual patients, hospitals and other healthcare providers and corporates. [1]
Dr Lal Pathlabs Ltd share price remains one of the actively tracked stocks on NSE among traders and long term investors.
The latest Dr Lal Pathlabs Ltd share price NSE movement reflects ongoing investor interest driven by company fundamentals, sector performance and broader market sentiment.
From a technical analysis perspective, the Dr Lal Pathlabs Ltd share price chart currently indicates a Bullish trend based on moving averages and RSI momentum analysis.
Technical Analysis
| Indicator | Value |
|---|---|
| Current Price | 1732.7 |
| RSI (14) | 57.44 |
| 50 DMA | 1637.47 |
| 200 DMA | 1502.35 |
| Trend | Bullish |
| A/D Rating | A+ |
| RS Rating | 74 |
| EPS Rating | 39 |
| TI65 | 1.07 |
| TI65 Trend | Bullish |
Pivot Points Analysis
Daily pivot points for Dr. Lal Path Labs Ltd. calculated using previous trading session data. These levels help traders identify intraday support, resistance and breakout zones using Classic Pivot Point methodology.
Classic Pivot Points
| Level | Value |
|---|---|
| R3 | ₹1775.3 |
| R2 | ₹1760.1 |
| R1 | ₹1746.4 |
| PP | ₹1731.2 |
| S1 | ₹1717.5 |
| S2 | ₹1702.3 |
| S3 | ₹1688.6 |
Financial Ratios
| Metric | Value |
|---|---|
| Market Cap | ₹ 28,287 Cr. |
| Current Price | ₹ 1,687 |
| High / Low | ₹ 1,804 / 1,272 |
| Stock P/E | 54.2 |
| Book Value | ₹ 150 |
| Dividend Yield | 0.83 % |
| ROCE | 28.0 % |
| ROE | 22.3 % |
| Face Value | ₹ 10.0 |
Quarterly Results
| Quarter | Sales | Profit | OPM |
|---|---|---|---|
| Mar 2023 | 491 | 57 | 24% |
| Jun 2023 | 541 | 84 | 27% |
| Sep 2023 | 601 | 111 | 30% |
| Dec 2023 | 539 | 82 | 26% |
| Mar 2024 | 545 | 86 | 27% |
| Jun 2024 | 602 | 108 | 28% |
| Sep 2024 | 660 | 131 | 31% |
| Dec 2024 | 597 | 98 | 26% |
| Mar 2025 | 603 | 156 | 28% |
| Jun 2025 | 670 | 134 | 29% |
| Sep 2025 | 731 | 152 | 31% |
| Dec 2025 | 660 | 91 | 27% |
| Mar 2026 | 703 | 132 | 27% |
Shareholding Pattern
| Holder | Holding |
|---|---|
| Promoters | 58.22% |
| FIIs | 10.00% |
| DIIs | 6.42% |
| Government | 0.00% |
| Public | 23.49% |
| Others | 1.86% |
| No. of Shareholders | 36,928 |
Pros and Cons
Pros
- Healthy return on equity of 22.3% indicating strong capital allocation efficiency.
- Strong technical momentum with price holding comfortably above the 50 DMA (1637.47).
- Outperforming over 70% of the entire market universe over the past 12 months.
Cons
- Valuation metrics appear elevated with a trailing P/E of 54.2, demanding high performance requirements.
Related NSE Stocks
Blue Jet Healthcare Limited
View Share Price Analysis →PB Fintech Limited
View Share Price Analysis →Jindal Stainless Limited
View Share Price Analysis →Cummins India Limited
View Share Price Analysis →DLF Limited
View Share Price Analysis →CG Power and Industrial Solutions Limited
View Share Price Analysis →Syrma SGS Technology Limited
View Share Price Analysis →Granules India Limited
View Share Price Analysis →Motherson Sumi Wiring India Limited
View Share Price Analysis →Coforge Limited
View Share Price Analysis →Olectra Greentech Limited
View Share Price Analysis →Garden Reach Shipbuilders & Engineers Limited
View Share Price Analysis →Frequently Asked Questions
What is the current technical trend and RSI for Dr Lal Pathlabs Ltd share?
Based on the latest closing data, the technical momentum for Dr Lal Pathlabs Ltd is currently evaluated as Bullish. The stock is exhibiting an RSI (14) of 57.44, indicating it is trading in a neutral balanced zone. Key tracking supports are currently located near the daily pivots, with price relative to the 50 DMA (1637.47) defining immediate multi-day trend patterns.
What are the key resistance and support pivot points for Dr Lal Pathlabs Ltd?
According to Classic Pivot Point methodologies, the core trading floor for Dr Lal Pathlabs Ltd today centers at a Pivot Point (PP) of ₹1731.2. Upside resistance challenges are calculated at R1: ₹1746.4, R2: ₹1760.1, and R3: ₹1775.3. Conversely, if selling pressure intensifies, immediate floor support targets are positioned at S1: ₹1717.5, S2: ₹1702.3, and S3: ₹1688.6.
How does the fundamental ROE and P/E ratio look for Dr Lal Pathlabs Ltd?
Dr Lal Pathlabs Ltd is currently trading with a valuation metrics context of a Stock P/E of 54.2, against a core structural efficiency Return on Equity (ROE) standing at 22.3 %. This fundamental operational efficiency baseline is coupled with an EPS Rating of 39, allowing investors to track how corporate profitability trends align with current price discovery cycles on the National Stock Exchange (NSE).
Should I buy or sell Dr Lal Pathlabs Ltd shares based on corporate rankings?
Our dynamic trade matrix suggests a status of: Speculative Momentum Phase (Neutral / Hold). Dr Lal Pathlabs Ltd is trading abov... For long-term portfolios, decision-making should match the stock's market performance profile, which currently displays an institutional Accumulation/Distribution (A/D) grade of A+, a Relative Strength (RS) ranking of 74, and long-term trend backing from the TI65 indicator (Bullish pattern).